欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/1692/001
药品名称Salflumix Easyhaler
活性成分
    • Fluticasone propionate 250.0 µg/dose
    • Salmeterol xinafoate 50.0 µg/dose
剂型Inhalation powder
上市许可持有人Orion Corporation, Finland
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Denmark (DK)
      Salflumix Easyhaler
    • Belgium (BE)
      Flutisamix Easyhaler 50 microgrammes/250 microgrammes/dose poudre pour inhalation
    • Luxembourg (LU)
      Flusisamix Easyhaler, 50 mcg /250 mcg, Poudre pour inhalation
    • Iceland (IS)
      Salflumix Easyhaler 50 míkrógram/250 míkróg/skammt innöndunarduft
    • Portugal (PT)
    • Italy (IT)
    • Norway (NO)
      Salflumix Easyhaler
    • Finland (FI)
    • Poland (PL)
      Salflumix Easyhaler
    • Latvia (LV)
      Salflumix Easyhaler 50 mikrogrami/250 mikrogrami/devā inhalācijas pulveris
    • Lithuania (LT)
      Fusamix Easyhaler 50 mikrogramų/250 mikrogramų/dozėje įkvepiamieji milteliai
    • Estonia (EE)
      SALFLUMIX EASYHALER
    • Hungary (HU)
      SAFUMIX EASYHALER 50 mikrogramm/250 mikrogramm/adag, inhalációs por
    • Czechia (CZ)
      Salflumix Easyhaler 50 mikrogramů/250 mikrogramů
    • Slovakia (SK)
      Salflumix Easyhaler 50 mikrogramov/250 mikrogramov/dávka
    • Slovenia (SI)
      Salflumix Easyhaler 50 mikrogramov/250 mikrogramov/odmerek prašek za inhaliranje
    • Croatia (HR)
      Fusamix Easyhaler 50 mikrograma + 250 mikrograma u jednoj dozi, prašak inhalata
许可日期2018/03/15
最近更新日期2024/10/02
药物ATC编码
    • R03AK06 salmeterol and fluticasone
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase